The week’s best buys

Allergy Therapeutics Investors Chronicle

This small, well-run biotech’s vaccine against severe grass allergies, Pollinex Quattro, is gaining traction in Europe. Not yet profit-making, but US trials are under way and there’s huge scope to expand the range. Buy. 19.8p.

Diageo The Sunday Times

The “good times are rolling again” at the spirits producer, as investors seek safe-haven consumer stocks. Strong US momentum should be boosted by favourable currency movements. Yields 3%. Buy. £21.07.

Equiniti Group The Mail on Sunday

Equiniti provides “vital” share scheme and pension services for customers including Royal Mail, the NHS and the Metropolitan Police. Growth is driven by regulation – there’s plenty of potential. Buy. 171.75p.

Restore The Times

Restore operates in a fragmented market, providing office services from shredding to removals. Acquisitions are feeding through into cost savings and increased profits, and earnings are highly visible. Buy. 322.5p.

Ricardo The Times

The specialist engineer’s most recent acquisition is an Italian motorcycle designer. Revenues are growing and the Mclaren super-car contract will add to profits. It will benefit from the lower pound. Buy. 758.5p.

SSP Group The Daily Telegraph

This operator of food outlets and franchises in airports and train stations has been a beneficiary of sterling’s plunge. Led by ex-wh Smith boss Kate Swann, it’s a solid investment with long-term growth drivers. Buy. 302.5p.